为了使您在Abcam官网的浏览体验更顺畅，请使用最新版本的浏览器比如 Google Chrome
Our Custom Services team has record of successfully developing RabMAb primary antibodies against challenging targets such as splice variants, point mutations, species-specific orthologs, post-translational modifications, and small molecule compounds. More than 550 institutions and 150 pharma, diagnostics and biotech companies have benefited from our custom antibody development.
You can submit immunogens as recombinant proteins, synthetic peptides, small molecules, cDNA expression vectors, or over expressing cells. Alternatively, you can provide the spleen of an immunized rabbit to initiate the monoclonal phase of antibody development. Or better yet, you can simply provide the target information, and we will assist with antigen design and produce the immunogens.
We also provide comprehensive services for antibody cloning, engineering, expression, and purification in addition to custom antibody development.
RabMAb monoclonal antibodies are used in research, doagnostics, and therapeutics
>9,000 RabMAb antibodies
>200 RabMAb antibody pairs
>15,000 antigens in pipeline
>300 EP clones are IHC ASR
5 FDA-approved RabMAb primaries
1 Phase I; 2 filing IND; 4 preclinical development
>3,000 custom antibodies developed
The rabbit immune system generates antibody diversity and optimizes affinity by mechanisms different from those of mice and other rodents. RabMAb technology produces reagents that combine the superior antigen recognition of a rabbit antibody with the specificity and consistency of a monoclonal. Two major advantages that set these apart from traditional mouse and rabbit antibodies are:
High specificity: Immunization of rabbits results in a highly diverse suite of B-lymphocytes and an abundance of splenocytes. The breadth of available cells means a greater chance of finding antibodies that distinguish between similar molecules and therefore improved specificity.
Harness the RabMAb advantages to develop antibodies that are
Custom services offer you